Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002611

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Veinrib Gadi · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X03/form4-05202021_040518.xml…